Prostatitis: US perspective

A. J. Schaeffer*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

52 Scopus citations

Abstract

The diagnosis and management of prostatitis syndromes is a challenge to the clinician. Careful history and examination of the prostate fluid and quantitative segmented bacteriologic cultures will lead to proper categorization into the recognized forms of the prostatitis syndrome. Antimicrobial therapy is effective in the majority of men with acute and chronic bacterial prostatitis (CBP). Fluoroquinolone agents appear to have an increasingly important role in this regard, although a randomized, prospective, double-blind study is still lacking. Alpha-1-selective blocking agents may relieve symptomatology of chronic pelvis pain syndrome (CPPS). Other non-prostatic sources of voiding symptoms should be sought and ruled out, especially malignancy or inflammatory disorders. Copyright (C) 1999 Elsevier Science B.V.

Original languageEnglish (US)
Pages (from-to)205-211
Number of pages7
JournalInternational Journal of Antimicrobial Agents
Volume11
Issue number3-4
DOIs
StatePublished - May 1 1999

Keywords

  • Pelvic pain
  • Prostatitis
  • Urinary tract infection

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Microbiology
  • Parasitology
  • Virology
  • Immunology and Allergy
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Prostatitis: US perspective'. Together they form a unique fingerprint.

Cite this